中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 3
Mar.  2002
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2002  >  18(3): 192-193

拉米夫定对慢性乙肝患者T细胞亚群影响的研究

  • Published Date: 2002-03-20
    Abstract
  • To study the influence of lamivuding to T-Lymphocyte-subsetes of chronic hepatitis B, 40 cases of the hepatitis B were treated with lamiyudine.The results showed that the recovery rate of ALT and the negative conversion of HBVDNA were 92.5% and 85% in the study group, they were significantly higher than those in normal controls (p<0.05) . CD 4 +, the ratios of CD 4 +/ CD 8 + rose obviously and CD 8 +descended obviously in the study group.There was no change in normal controls (p<0.05) .The results indicated that lamivudine was efficatious for chronic hepatitis B, lamivudine could improve the immunologic function of patients with chronic hepatitis B, the negative conversion of HBVDNA were higher in the patients with better immunologic function.

     

    • FullText(HTML)
    • References(7)
  • [1]马存根, 刘淑璋, 王力声, 等乙肝患者T淋巴细胞亚群变化与血清HBV -DNA关系的观察[J]临床肝胆病杂志, 1994, 10 (1) ∶47
    [2] ScullyLJ, DrownD , LloydC , etal.ImmunologicalstudysbeforeandduringinterferontherapyinchronicHBVinfection:identificationoffactorspredictingresponse[J]Hepatology, 1990, 12 (5) ∶1111-1117.
    [3]李宝群慢性活动性乙型肝炎患者细胞亚群状态的研究[J]中国医科大学学报, 1990, 1∶43-45.
    [4]YangPM , SuIJ, LaiMY .etal.Immunohistochemicalstudiesonin terahepaticlymphocyteinfiltratesinchronictypeBhepatiswithspe cialemphasisontheactivitionstatusofthelymphocytes[J]AmJGastroenterology, 1998, 83 (9) ∶948-953.
    [5]王克霞, 王健, 张立华HBV侵入PBMC后对乙肝患者细胞免疫功能的影响[J]锦州医学院学报, 1998, 19 (3) ∶19
    [6]彭文伟主编传染病学[M ]第5版, 北京人民卫生出版社2001P43
    [7]ChingLungLai, ManFungYuen.profoundsuppressionofhepatitisBvirusreplicationwithlamivudine[J]JournalofMedicalVirology, 2000, 6 (3) ∶367-373.
    • Relative Articles

  • Relative Articles

    [1]Hongxia LI, Yimeng SUN, Hongtao ZHANG, Shuwang HAN, Delin ZHANG, Haitao SHANG, Wu GUO, Junjian LIU, Zhonglian LI. Role of HBV DNA polymerase in mediating the immune escape of tumor cells in HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(12): 2858-2866. doi: 10.3969/j.issn.1001-5256.2023.12.017
    [2]Zhen ZhiJun.

    A study on optimizing reporting process for hepatitis C virus antibody test for blood donors in blood center′ laboratory

    [J]. Journal of Clinical Hepatology, 2015, 31(8): 1275-1277. doi: 10.3969/j.issn.1001-5256.2015.08.022
    [4]Ma HongBo, Lang ZhenWei, Huang DeZhuang, Yan HuiPing, Luo ChaoXia. Study on transfusion transmitted virus in liver tissue of people with no viral hepatitis by the method of in situ hybridization.[J]. Journal of Clinical Hepatology, 2004, 20(5): 277-278+321.
    [7]Jiao JianZhong, Liu WangGuo, Li AiYue, Jiao JianXin, Qiu YingFeng, Shen Xu. Clinical Study on Serology of TT Virus Infection and Pathogenicity in Lanzhou[J]. Journal of Clinical Hepatology, 2001, 17(1): 47-48.
    [8]Wu LongRen, Han XueJi, Cui WeiZhe, Yin MingShi, Po HongXin, Tai YongRi. TTV tvirus infection among 45 cases of hepatitis B and C patients in yan bian city[J]. Journal of Clinical Hepatology, 2000, 16(4): 249-250.
    [9]Tan XinCheng, Wang Yun, Zhang XiCheng, Liu ZhiHua, Li XiaoPing, Wang LeNong. The clinical characters of Transfusion transmitted virus positive hepatitis patients[J]. Journal of Clinical Hepatology, 2000, 16(4): 234-235.
    [11]Wu XiaoMan, Guo HaiBo, Lie HaiTao. The quantitative and qualitative PCR detection and clinical application of HBV-DNA[J]. Journal of Clinical Hepatology, 2000, 16(4): 226-227.
    [12]Wang ZhaoQuan, Shu Bo, Li Ying, Li ZhiWei, Wang JingYan, Wang Mei, Hong Ming, Jin GuoXian, Zhi YaQing. Detection of TTV Incidence Among Difeerent Types of Viral Hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(4): 239-241.
    • Supplements(0)
    • Cited By
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-042024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-030510152025
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 7.6 %FULLTEXT: 7.6 %META: 89.0 %META: 89.0 %PDF: 3.4 %PDF: 3.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 1.4 %其他: 1.4 %其他: 0.3 %其他: 0.3 %上海: 2.2 %上海: 2.2 %丽水: 0.8 %丽水: 0.8 %北京: 8.7 %北京: 8.7 %南宁: 0.3 %南宁: 0.3 %南昌: 0.3 %南昌: 0.3 %吉林: 0.6 %吉林: 0.6 %哥伦布: 0.8 %哥伦布: 0.8 %张家口: 0.8 %张家口: 0.8 %武汉: 0.3 %武汉: 0.3 %芒廷维尤: 40.4 %芒廷维尤: 40.4 %芝加哥: 0.6 %芝加哥: 0.6 %莫斯科: 0.3 %莫斯科: 0.3 %西宁: 40.2 %西宁: 40.2 %长春: 2.0 %长春: 2.0 %其他其他上海丽水北京南宁南昌吉林哥伦布张家口武汉芒廷维尤芝加哥莫斯科西宁长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3569) PDF downloads(879) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[3590]YesterdayPV[6562]TodayIP[971]TodayPV[1322]Online[176]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return